Abstract
These clinical recommendations summarized currently available evidence on diagnosis and management of patients with pulmonary embolism. When compared to previous version of recommendations, this document has introduced simplified clinical prognostic scales and a new risk stratification system including intermediate risk. Novel approach to anticoagulant therapy have been also reviewed including systemic thrombolysis, catheterdirected treatment, vitamin K antagonists and new oral anticoagulants.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have